Atlas Trials

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Clinical trial NCT03101462 · COMPLETED

Trial details

NCT number
NCT03101462
Sponsor
St. Louis University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2011-02-24
Primary completion
2011-05-13
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.